Correlation Between 23Andme Holding and Immunoprecise Antibodies
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Immunoprecise Antibodies, you can compare the effects of market volatilities on 23Andme Holding and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Immunoprecise Antibodies.
Diversification Opportunities for 23Andme Holding and Immunoprecise Antibodies
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Immunoprecise is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Immunoprecise Antibodies go up and down completely randomly.
Pair Corralation between 23Andme Holding and Immunoprecise Antibodies
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Immunoprecise Antibodies. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.11 times less risky than Immunoprecise Antibodies. The stock trades about -0.08 of its potential returns per unit of risk. The Immunoprecise Antibodies is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 546.00 in Immunoprecise Antibodies on August 25, 2024 and sell it today you would lose (508.00) from holding Immunoprecise Antibodies or give up 93.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Immunoprecise Antibodies
Performance |
| Timeline |
| 23Andme Holding |
| Immunoprecise Antibodies |
23Andme Holding and Immunoprecise Antibodies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Immunoprecise Antibodies
The main advantage of trading using opposite 23Andme Holding and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.| 23Andme Holding vs. Eliem Therapeutics | 23Andme Holding vs. HCW Biologics | 23Andme Holding vs. RenovoRx | 23Andme Holding vs. Tempest Therapeutics |
| Immunoprecise Antibodies vs. Eliem Therapeutics | Immunoprecise Antibodies vs. HCW Biologics | Immunoprecise Antibodies vs. RenovoRx | Immunoprecise Antibodies vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |